4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #medications #table ... #comparison #management
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed Medical Therapy ... and CKD • Class ... diuretics, MRA, SGLT2i ... Directed #Medical #Therapy ... #GDMT #CKD #HFrEF
Diets and Inflammatory Bowel Disease (IBD)
Diet affects IBD by 3 mechanisms
1. Microbiome ( ↓ diversity)
2. Mucosal
CD > UC • Patient ... balanced, nutritious Table ... NG tube); • CD-TREAT ... #Nutrition #comparison ... #table #management